Bernstein Lab / Cancer Epigenetics

Cancer Epigenetics

Shelby Roseman, PhD

Shelby joined the lab as a research fellow in October 2023 after completing her PhD at Harvard University. During her PhD, she used chemical genomics to study 3D chromatin structure. She is interested in understanding and targeting the epigenetic mechanisms that contribute to cancer.

James Morrow, MD/PhD

James is a Pediatric Oncology Fellow at Dana-Farber/Boston Children’s Hospital where he currently treats pediatric patients with cancer diagnoses. He completed his MD/PhD at Case Western Reserve University. His graduate work identified enhancer dysregulation as a driver of osteosarcoma metastasis. He joined the Bernstein lab in September 2022 as a research fellow. His work will apply single cell … Continued

Alba Meira, PhD

Alba joined the lab in 2021 as a Sir Henry Wellcome Fellow. Originally from Spain, she undertook her PhD at the University of Oxford before moving to Boston. She is interested in deciphering in the epigenetic mechanisms that lead to tumor development and evolution using single cell technologies.

Zeyu Chen, PhD

Interests: Epigenetic circuits in immune cells; High dimensional profiling in tumor microenvironments Zeyu Chen did his undergraduate at Peking University in Beijing, China, studying stem cell genetic engineering in Dr. Hongkui Deng’s lab. He then worked as a research assistant in Dr. Richard Flavell’s lab at Yale for one year, and did his Ph.D. at University … Continued

Eli Cytrynbaum

Interests: Cell fate decisions and epigenetic buffering; tissue specific DNA architecture based vulnerabilities to cancer Eli joined the lab in 2020 and is currently studying the role of mitochondrial MDM2 in liposarcoma, both from a wet lab and computational perspective.